User profiles for Roberto Furlan

Roberto Furlan

Clinical Neuroimmunology Unit, Institute of Experimental Neurology, Division of …
Verified email at hsr.it
Cited by 20715

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

…, B Vai, I Bollettini, EMT Melloni, R Furlan… - Brain, behavior, and …, 2020 - Elsevier
Infection-triggered perturbation of the immune system could induce psychopathology, and
psychiatric sequelae were observed after previous coronavirus outbreaks. The spreading of …

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

…, R Galli, U Del Carro, S Amadio, A Bergami, R Furlan… - Nature, 2003 - nature.com
Widespread demyelination and axonal loss are the pathological hallmarks of multiple sclerosis.
The multifocal nature of this chronic inflammatory disease of the central nervous system …

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism

…, M Martinello, A Cattalini, A Bergami, R Furlan… - Nature, 2005 - nature.com
In degenerative disorders of the central nervous system (CNS), transplantation of neural
multipotent (stem) precursor cells (NPCs) is aimed at replacing damaged neural cells 1 , 2 . …

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up

…, R De Lorenzo, C Magnaghi, S Poletti, R Furlan… - Brain, behavior, and …, 2021 - Elsevier
COVID-19 outbreak is associated with mental health implications during viral infection and
at short-term follow-up. Data on psychiatric and cognitive sequelae at medium-term follow-up …

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

…, D Franciotta, JL Frederiksen, JO Fleming, R Furlan… - Neurology, 2009 - AAN Enterprises
There is a long history of research into body fluid biomarkers in neurodegenerative and
neuroinflammatory diseases. However, only a few biomarkers in CSF are being used in clinical …

Acid sphingomyelinase activity triggers microparticle release from glial cells

…, E Menna, L Saglietti, EH Schuchman, R Furlan… - The EMBO …, 2009 - embopress.org
We have earlier shown that microglia, the immune cells of the CNS, release microparticles
from cell plasma membrane after ATP stimulation. These vesicles contain and release IL‐1β, …

Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine

…, H Del Portillo, S El Andaloussi, TF Trček, R Furlan… - 2016 - ACS Publications
Recent research has demonstrated that all body fluids assessed contain substantial amounts
of vesicles that range in size from 30 to 1000 nm and that are surrounded by phospholipid …

Secondary progressive multiple sclerosis: current knowledge and future challenges

M Rovaris, C Confavreux, R Furlan, L Kappos… - The Lancet …, 2006 - thelancet.com
The secondary progressive phase of multiple sclerosis (MS), which is characterised by a
steady accrual of fixed disability after an initial relapsing remitting course, is not clearly …

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis

…, F Cecconi, L Battistini, R Furlan… - Journal of …, 2009 - Soc Neuroscience
Neurodegeneration is the irremediable pathological event occurring during chronic
inflammatory diseases of the CNS. Here we show that, in experimental autoimmune …

Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study

…, R Hintzen, L Kappos, R Furlan… - Multiple Sclerosis …, 2015 - journals.sagepub.com
Background and objective: We explored which clinical and biochemical variables predict
conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS…